isoxazoles has been researched along with Psoriasis in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (50.00) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foley, P; Kelly, JB; Strober, BE | 1 |
| López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L | 1 |
| Frambach, Y; Gerdes, S; Jacobi, A; Mössner, R; Philipp, S; Weyergraf, AJ; Wilsmann-Theis, D | 1 |
| Bitterman, H; Cohen, AD; Cohen, Y; Dreiher, J; Feldhamer, I; Greenberg-Dotan, S; Hammerman, A; Harman-Boehm, I; Moser, H; Shalom, G; Zisman, D | 1 |
| Divate, D; Gangurde, S; Pawar, S; Pund, S | 1 |
| Affleck, AG; Williams, H | 1 |
| De Panfilis, G; Di Nuzzo, S; Zanni, M | 1 |
| Borrego, L; Guillermo, N; Hernández-Machín, B; Melwani, PM; Peñate, Y; Soler, E | 1 |
| Chang, YJ; Chen, LA; Hsu, YL; Su, LH; Tsai, TH | 1 |
| Aldi, M; Casadio, C; Gaddoni, G; Giacomini, F; Patrizi, A; Savoia, F; Spadola, G | 1 |
| Boyd, AS | 1 |
| Daudén, E; Gallo, E; García-Diez, A; Navarro, R; Santiago Sánchez-Mateos, D | 1 |
| Wetter, DA | 1 |
| Barba-Gómez, JF; Guevara-Gutiérrez, E; Ornelas-Aguirre, JM; Rodríguez-Castellanos, MA; Salazar-Páramo, M; Tlacuilo-Parra, JA | 1 |
| Garg, G; Thami, GP | 1 |
| Houtman, PM | 1 |
| Behrens, F; Falk, F; Kaltwasser, JP; Nash, P; Thaçi, D | 1 |
| Chen, B; Holtz, R; Huang, WH; Lee, AR; Liu, C; Martin, R; Shaw, J | 1 |
| Bagot, M; Claudepierre, P | 1 |
| Beckmann, I; Hummel, KM; Mössner, R; Neumann, C; Reich, K | 1 |
| Pfeiffer, C; Wozel, G | 1 |
5 review(s) available for isoxazoles and Psoriasis
| Article | Year |
|---|---|
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
New-onset psoriasis associated with etanercept therapy.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Male; Methotrexate; Prednisolone; Psoriasis; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Sulfasalazine; Tumor Necrosis Factor-alpha | 2010 |
Leflunomide in dermatology.
Topics: Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis; Skin Diseases | 2012 |
Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
Topics: Adalimumab; Adult; Alopecia Areata; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Humans; Isoxazoles; Leflunomide; Male; Psoriasis; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2012 |
[Leflunomide--a new drug for pharmacological immunomodulation].
Topics: Animals; Autoimmune Diseases; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis; Skin Diseases | 2002 |
3 trial(s) available for isoxazoles and Psoriasis
| Article | Year |
|---|---|
Leflunomide in the treatment of psoriasis: results of a phase II open trial.
Topics: Adolescent; Adult; Aged; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2004 |
Leflunomide in psoriasis and psoriatic arthritis: a preliminary study.
Topics: Adjuvants, Immunologic; Adult; Aged; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Psoriasis; Treatment Outcome | 2004 |
Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Psoriasis; Quality of Life; Skin | 2006 |
14 other study(ies) available for isoxazoles and Psoriasis
| Article | Year |
|---|---|
Leflunomide: psoriasis, lupus.
Topics: Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Psoriasis | 2013 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis | 2015 |
Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
Topics: Acitretin; Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Fumarates; Germany; Humans; Infliximab; Isoxazoles; Keratolytic Agents; Leflunomide; Male; Methotrexate; Middle Aged; Prednisolone; Psoriasis; Retrospective Studies | 2015 |
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Biological Factors; Causality; Cohort Studies; Comorbidity; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Herpes Zoster; Herpes Zoster Vaccine; Humans; Incidence; Isoxazoles; Male; Methotrexate; Middle Aged; Multivariate Analysis; Phototherapy; Psoriasis; Risk Factors; Sex Distribution; Ustekinumab | 2015 |
Transcutaneous delivery of leflunomide nanoemulgel: Mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity.
Topics: Adhesiveness; Administration, Cutaneous; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Stability; Emulsions; Excipients; Gels; Hardness Tests; Humans; Isoxazoles; Leflunomide; Melanoma; Nanostructures; Particle Size; Psoriasis; Skin Absorption; Viscosity | 2015 |
Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?
Topics: Evidence-Based Medicine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Psoriasis; Randomized Controlled Trials as Topic; Young Adult | 2008 |
Cutaneous ulceration induced by leflunomide in a psoriatic patient.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Breast; Female; Humans; Isoxazoles; Leflunomide; Psoriasis; Skin; Skin Ulcer | 2009 |
Leflunomide in the treatment of palmoplantar pustulosis.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hand Dermatoses; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2009 |
A case of eczematous and vesicular dermatitis during anti-TNFalpha therapy for rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnostic Errors; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Eczema; Etanercept; Female; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Pruritus; Psoriasis; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Skin Diseases, Vesiculobullous; Tumor Necrosis Factor-alpha | 2011 |
Palmoplantar pustulosis.
Topics: Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Middle Aged; Psoriasis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2013 |
[The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
Topics: Dermatologic Agents; Humans; Isoxazoles; Leflunomide; Photochemotherapy; Psoriasis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
Inhibition of tumour necrosis factor-alpha secretion from EpiDermTM tissues by a novel small molecule, UTL-5d.
Topics: Biological Transport; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Feasibility Studies; Humans; Immunosuppressive Agents; Isoxazoles; Janus Kinase 3; Keratinocytes; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2007 |
[Psoriatic arthritis].
Topics: Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis | 2008 |
Treatment of severe psoriasis and psoriatic arthritis with leflunomide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis | 2002 |